Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family

Journal of Clinical Oncology

Volumn 18, Issue 1, 2000, Pages 204-213

  De Alava, Enrique ^a   Gerald, William L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CELL PROLIFERATION; CHIMERA; CHROMOSOME TRANSLOCATION; EWING SARCOMA; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MESENCHYME CELL; MOLECULAR BIOLOGY; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; TARGET CELL; TISSUE SPECIFICITY;

EID: 0033989280     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.1.204     Document Type: Review

References (87)

1. Stout AP: A tumor of the ulnar nerve. Proc NY Pathol Soc 12:2-12, 1918
2. Ewing J: Diffuse endothelioma of bone. Proc NY Pathol Soc 21:17-24, 1921
3. Askin FB, Rosai J, Sibley RK, et al: Malignant small cell tumor of the thoracopulmonary region in childhood: A distinctive clinicopathologic entity of uncertain histogenesis. Cancer 43:2438-2451, 1979
4. Tefft M, Vawter GF, Mitus A: Paravertebral "round cell" tumors in children. Radiology 92:1501-1509, 1969
5. Llombart-Bosch A, Lacombe MJ, Contesso G, et al: Small round blue cell sarcoma of bone mimicking atypical Ewing's sarcoma with neuroectodermal features: An analysis of five cases with immunohistochemical and electron microscopic support. Cancer 60:1570-1582, 1987
6. Jaffe R, Santamaria M, Yunis EJ, et al: The neuroectodermal tumor of bone. Am J Surg Pathol 8:885-898, 1984
7. Angervall L, Enzinger FM: Extraskeletal neoplasm resembling Ewing's sarcoma. Cancer 36:240-251, 1975
8. Kovar H: Ewing's sarcoma and peripheral primitive neuroectodermal tumors after their genetic union. Curr Opin Oncol 10:334-342, 1998
9. Zucman-Rossi J, Batzer M, Stoneking M, et al. Interethnic polymorphism of EWS intron 6: Genome plasticity mediated by Alu retroposition and recombination. Hum Genet 99:357-363, 1997
10. Terrier P, Llombart-Bosch A, Contesso G: Small round blue cell tumors in bone: Prognostic factors correlated to Ewing's sarcoma and neuroectodermal tumors. Semin Diagn Pathol 13:250-257, 1996
11. Dehner L: Primitive neuroectodermal tumor and Ewing's sarcoma. Am J Surg Pathol 17:1-13, 1993
12. MIC2. Am J Pathol 139:317-326, 1991
13. Ambros I, Ambros P, Strehl S, et al: MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 67:1886-1893, 1991
14. MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 18:486-494, 1994
15. Sandberg AA: The Chromosomes in Human Cancer and Leukemia. New York, NY, Elsevier Science Publishing Co, Inc, 1990
16. Aurias A, Rimbaut C, Buffe D, et al: Chromosomal translocations in Ewing's sarcoma. N Engl J Med 309:496-497, 1983
17. Whang-Peng J, Triche TJ, Knutsen T, et al: Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 311:584-585, 1984
18. Delattre O, Zucman J, Plougastrel B, et al: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359:162-165, 1992
19. Zucman J, Delattre O, Desmaze C, et al: Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosom Cancer 5:271-277, 1992
20. Ohno T, Ouchida M, Lee L, et al: The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9:3087-3097, 1994
21. Rabbitts TH, Forster A, Larson R, et al: Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4:175-180, 1993
22. Crozat A, Aman P, Mandahl N, et al: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640-644, 1993
23. Zinszner H, Albalat R, Ron D: A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev 8:2513-2526, 1994
24. Berlotti A, Lutz Y, Heard DJ, et al: hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J 15:5022-5031, 1996
25. Hackl W, Lührmann R: Molecular cloning and subcellular localisation of the snRNP-associated protein 69KD, a structural homologue of the proto-oncoproteins TLS and EWS with RNA and DNA-binding properties. J Mol Biol 264:843-851, 1996
26. Alliegro MC, Alliegro MA: A nuclear protein regulated during the transition from active to quiescent phenotype in cultured endothelial cells. Dev Biol 174:288-297, 1996
27. Stolow DT, Haynes SR, Cabeza A: Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucleic Acids Res 23:835-843, 1995
28. Immanuel D, Zinszner H, Ron D: Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol Cell Biol 15:4562-4571, 1995
29. Burd CG, Dreyfuss G: Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615-621, 1994
30. Bertolotti A, Melot T, Acker J, et al: EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: Interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol Cell Biol 18:1489-1497, 1998
31. Petermann R, Mossier BM, Aryee DN, et al: Oncogenic EWS-FIi1 interacts with hsRPB7, a subunit of human RNA polymerase II. Oncogene 17:603-610, 1998
32. Hromas R, Klemsz M: The ETS oncogene family in development, proliferation and neoplasia. Int J Hematol 59:257-265, 1994
33. Sharrocks AD, Brown AL, Ling Y, et al: The ETS-domain transcription factor family. Int J Biochem Cell Biol 29:1371-1387, 1997
34. Dittmer J, Nordheim A: Ets transcription factors and human disease. Biochim Biophys Acta 1377:F1-11, 1998
35. Wasylyk B, Hahn SL, Giovane A: The Ets family of transcription factors. Eur J Biochem 211:7-18, 1993
36. Zucman J, Melot T, Desmaze C, et al: Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J 12:4481-4487, 1993
37. Sorensen PHB, Lessnick SL, Lopez-Terrada D, et al: A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6:146-151, 1994
38. Jeon I-S, Davis JN, Braun BS, et al: A variant Ewing's sarcoma translocation t(7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229-1239, 1995
39. Urano F, Umezawa A, Hong W, et al: A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 219:608-612, 1996
40. Peter M, Couturier J, Pacquement H, et al: A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159-1164, 1997
41. Wasylyk B, Hagman J, Gutierrez-Hartmann A: Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 23:213-216, 1998
42. Zucman J, Delattre O, Desmaze C, et al: EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 4:341-345, 1993
43. Ladanyi M, Gerald WL: Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res 54:2837-2840, 1994
44. Panagopoulos I, Hoglund M, Mertens F, et al: Fusion of EWS and CHOP genes in myxoid liposarcoma. Oncogene 12:489-494, 1996
45. Labelle Y, Zucman F, Stenman G, et al: Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet 4:2219-2226, 1995
46. Clark J, Benjamin H, Gill S, et al: Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene 12:229-235, 1996
47. Panagopoulos I, Aman P, Fioretos T, et al: Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22). Genes Chromosom Cancer 11:256-262, 1994
48. Ichikawa H, Shimizu K, Hayashi Y, et al: An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54:2865-2868, 1994
49. Armengol G, Tarkkanen M, Virolainen M, et al: Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer 75:1403-1409, 1997
50. Hattinger CM, Rumpler S, Strehl S, et al: Prognostic impact of deletions at 1p36 and numerical aberrations in ES/PNET. Genes Chromosom Cancer 24:243-254, 1999
51. Kovar H, Auinger A, Jug G, et al: Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. Oncogene 8:2683-2690, 1993
52. Hamelin R, Zucman J, Melot T, et al: p53 mutations in human tumors with chimeric EWS/FLI-1 genes. Int J Cancer 57:336-340, 1994
53. Kovar H, Jug G, Aryee DN, et al: Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 15:2225-2232, 1997
54. May WA, Lessnick SL, Braun BS, et al: The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13:7393-7398, 1993
55. Ohno T, Rao VN, Reddy ESP: EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res 53:5859-5863, 1994
56. Bailly RA, Bosselut R, Zucman J, et al: DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14:3230-3241, 1994
57. Mao X, Miesfeldt S, Yang H, et al: The FLI-I and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem 269:18216-18222, 1994
58. Zhang D, Paley A, Childs G: The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J Biol Chem 273:18086-18091, 1998
59. May WA, Gishizky ML, Lessnick SL, et al: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A 90:5752-5756, 1993
60. Braun BS, Frieden R, Lessnick SL, et al: Identification of target genes for the Ewing's sarcoma EWS/Fli fusion protein by representational difference analysis. Mol Cell Biol 15:4623-4630, 1995
61. Johnston SH, Rauskolb C, Wilson R, et al: A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 124:2245-2254, 1997
62. Yuan YP, Schultz J, Mlodzik M, et al: Secreted fringe-like signaling molecules may be glycosyltransferases. Cell 88:9-11, 1997
63. May WA, Arvand A, Thompson AD, et al: EWS-FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet 17:495-497, 1997
64. Thompson AD, Braun BS, Arvand A, et al: EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS-FLI1 fusion gene. Oncogene 13:2649-2658, 1996
65. Arvand A, Bastians H, Welford SM, et al: EWS-FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17:2039-2045, 1998
66. Magnaghi-Jaulin L, Masutani H, Robin P, et al: SRE elements are binding sites for the fusion protein EWS-FLI-1. Nucleic Acids Res 24:1052-1058, 1996
67. Watson DK, Robinson L, Hodge DR, et al: FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene 14:213-221, 1997
68. Lessnick SL, Braun BS, Denny CT, et al: Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 10:423-431, 1995
69. Toretsky JA, Kalebic T, Blakesley V, et al: The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. J Biol Chem 272:30822-30827, 1997
70. Tanaka K, Iwakuma T, Harimaya K, et al: EWS-FIi1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 99:239-247, 1997
71. Toretsky JA, Connell Y, Neckers L, et al: Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides. J Neurooncol 31:9-16, 1997
72. Kovar H, Aryee DN, Jug G, et al: EWS-FLI1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ 7:429-437, 1996
73. Yi H, Fujimura Y, Ouchida M, et al: Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 14:1259-1268, 1997
74. Delattre O, Zucman J, Melot T, et al: The Ewing family of tumors: A subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294-299, 1994
75. de Alava E, Ladanyi M, Rosai J, et al: Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction: A specific diagnostic assay. Am J Pathol 147:1584-1591, 1995
76. Barr FG, Chatten J, D'Cruz CM, et al: Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 273:553-557, 1995
77. Ladanyi M: The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 4:162-173, 1995
78. Pfleiderer C, Zoubek A, Gruber B, et al: Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR. Int J Cancer 21:135-139, 1995
79. West DC, Grier HE, Swallow MM, et al: Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor. J Clin Oncol 15:583-588, 1997
80. de Alava E, Lozano MD, Patino A, et al: Ewing family tumors: Potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples. Diagn Mol Pathol 7:152-157, 1998
81. Fagnou C, Michon J, Peter M, et al: Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. J Clin Oncol 16:1707-1711, 1998
82. Zoubek A, Ladenstein R, Windhager R: Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: A preliminary evaluation. Int J Cancer 79:56-60, 1998
83. Zoubek A, Pfleiderer C, Salzer-Kuntschik M, et al: Variability of EWS chimaeric transcripts in Ewing tumours: A comparison of clinical and molecular data. Br J Cancer 70:908-913, 1994
84. Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al: Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14:1245-1251, 1996
85. de Alava E, Kawai A, Healey JH, et al: EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16:1248-1255, 1998
86. Lin PP, Brody RI, Hamelin A, et al: Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res 59:1428-1432, 1999
87. Goletz TJ, Mackall CL, Berzofsky JA, et al: Molecular alterations in pediatric sarcomas: Potential targets for immunotherapy. Sarcoma 2:77-87, 1998